Use of botulinum toxin in strabismus

Current Opinion in Ophthalmology

Volumn 17, Issue 5, 2006, Pages 435-440

  Crouch, Eric R ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

Botulinum; Cranial nerve palsy; External ophthalmoplegia; Nystagmus; Strabismus

Indexed keywords

BOTULINUM TOXIN;

ANAPHYLAXIS; CONVERGENT STRABISMUS; CRANIAL NERVE PARALYSIS; DATA ANALYSIS; DIPLOPIA; DIVERGENT STRABISMUS; DRUG FATALITY; EVIDENCE BASED MEDICINE; EYE INJURY; EYE MUSCLE PARALYSIS; EYELID DISEASE; HUMAN; INJECTION SITE REACTION; MUSCLE INJURY; MYDRIASIS; NYSTAGMUS; OPHTHALMOPLEGIA; OSCILLOPSIA; PARALYSIS; PERFORATING EYE INJURY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PTOSIS; RETROBULBAR HEMORRHAGE; REVIEW; SENSORY DYSFUNCTION; STRABISMUS; TREATMENT INDICATION;

BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS, TYPE A; HUMANS; NEUROMUSCULAR AGENTS; OCULOMOTOR MUSCLES; STRABISMUS;

EID: 33748280198     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.icu.0000243018.97627.4c     Document Type: Review

References (48)

1. Scott AB. Pharmacologic weakening of extraocular muscles. Invest Ophthal Vis Sci 1973; 12:924-927.
2. Scott AB. Botulinum toxin: treatment of strabismus. Focal Points 1989; VII:1-11.
3. Scott AB, Magoon EH, McNeer KW, et al. Botulinum treatment of strabismus in children. Trans Am Ophthal Soc 1989; 87:174-184.
4. Kaltreider SA, Kennedy RH, Woog JJ, et al. Cosmetic oculofacial applications of botulinum toxin: a report by the American Academy of Ophthalmology. Ophthalmology 2005; 112:1159-1167.
5. O'Day J. Use of botulinum toxin in neuro-ophthalmology. Curr Opin Ophthalmol 2001; 12:419-422.
6. Scott AB. Development of botulinum toxin therapy. Dermatol Clin 2004; 22:131-133.
7. Jordan DR, Anderson RL. Essential blepharospasm. Focal Points 1988; VI:1-12.
8. Benabent EC, Garcia Hermosa P, Arrazola MT, Alio y Sanz JL. Botulinum toxin injection without electromyographic assistance. J Pediatr Ophthalmol Strabismus 2002; 39:231-234.
9. Patel BCK, Anderson RL. Essential blepharospasm and related diseases. Focal Points 2000; XVIII:1-14.
10. Cote TR, Mohan AK, Polder JA, et al. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005; 53:407-415.
11. Li M, Goldberger BA, Hopkins C. Fatal case of BOTOX-related anaphylaxis? J Forensic Sci 2005; 50:169-172. A case of possible fatal anaphylaxis related to botulinum-lidocaine administration was reported, although direct causation was not determined.
12. Liu M, Lee HC, Hertle RW, Ho AC. Retinal detachment from inadvertent intraocular injection of botulinum toxin A. Am J Ophthalmol 2004; 137:201-202.
13. Jeoung JW, Lee MJ, Hwang JM. Bilateral lateral rectus recession versus unilateral recess-resect procedure for exotropia with a dominant eye. Am J Ophthalmol 2006; 141:683-688. The success rate with 10 prism diopters for exotropia surgery with unilateral recess-resect was 83.3% (55 of 66 patients). The authors recommend unilateral recess-resect over bilateral rectus recession in patients with exotropia and a dominant eye.
14. Bishop F, Doran RM. Adjustable and nonadjustable strabismus surgery: a retrospective case-matched study. Strabismus 2004; 12:3-11.
15. Livir-Rallatos G, Gunton KB, Calhoun JH. Surgical results in large-angle exotropia. J AAPOS 2002; 6:77-80.
16. Mohan K, Ram J, Sharma A. Comparison between adjustable and nonadjustable hang-back muscle recession for concomitant exotropia. Indian J Ophthalmol 1998; 46:21-24.
17. Wisnicki HJ, Repka MX, Raab E, et al. A comparison of the success rates of resident and attending strabismus surgery. J Pediatr Ophthalmol Strabismus 1993; 30:118-121.
18. Repka MX, Guyton DL. Comparison of hang-back medial rectus recession with conventional recession. Ophthalmology 1988; 95:782-787.
19. Wisnicki HJ, Repka MX, Guyton DL. Reoperation rate in adjustable strabismus surgery. J Pediatr Ophthalmol Strabismus 1988; 25:112-114.
20. Siatkowski RM. Third, fourth, and sixth nerve palsies. Focal Points 1996; XIV:1-14.
21. Holmes JM, Leske DA, Christiansen SP. Initial treatment outcomes in chronic sixth nerve palsy. J AAPOS 2001; 5:370-376.
22. Kao LY, Chao AN. Subtenon injection of botulinum toxin for treatment of traumatic sixth nerve palsy. J Pediatr Ophthalmol Strabismus 2003; 40:27-30.
23. Holmes JM, Leske DA. Long-term outcomes after surgical management of chronic sixth nerve palsy. J AAPOS 2002; 6:283-288.
24. Merino P, Gomez de Liano P, Garcia C, et al. Bilateral superior oblique palsy and botulinum toxin. Arch Soc Esp Oftalmol 2004; 79:119-123.
25. Garnham L, Lawson JM, O'Neill D, Lee JP. Botulinum toxin in fourth nerve palsies. Aus N Z J Ophthalmol 1997; 25:31-35.
26. Dawson EL, Marshman WE, Lee JP. Role of botulinum toxin A in surgically overcorrected exotropia. J AAPOS 1999; 3:269-271.
27. Tejefor J, Rodríguez JM. Retreatment of children after surgery for acquired esotropia: reoperation versus botulinum injection. Br J Ophthalmol 1998; 82:110-114.
28. Tengtrisorn S, Treyapun N, Tantisarasart T. Botulinum A toxin therapy on esotropia in children. J Med Assoc Thai 2002; 85:1189-1197.
29. Khan S. Two horizontal rectus eye muscle surgery combined with botulinum toxin for the treatment of very large angle esotropia A pilot study. Binocul Vis Strabismus Q 2005; 20:15-20. Six of the eight patients were corrected within 10 prism diopters of orthophoria. Undercorrections occurred in two patients with 85-100 prism diopters of esotropia, and one patient developed postoperative strabismic amblyopia that was successfully treated.
30. Ruiz MF, Alvarez MT, Sanchez-Garrido CM, et al. Surgery and botulinum toxin in congenital esotropia. Can J Ophthalmol 2004; 39:639-649.
31. Dawson EL, Lee JP. Does Botulinum toxin have a role in the treatment of small-angle esotropia? Strabismus 2004; 12:257-260.
32. McNeer KW, Tucker MG, Spencer RF. Botulinum toxin management of essential infantile esotropia in children. Arch Ophthalmol 1997; 115:1411-1418.
33. McNeer KW, Tucker MG, Guerry C, et al. Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin. J Pediatr Ophthalmol Strabismus 2003; 40:288-292.
34. Ing MR. Botulinum alignment for congenital esotropia. Ophthalmology 1993; 100:318-322.
35. Sener EC, Sanac AS. Efficacy and complications of dose increments of botulinum toxin-A in the treatment of horizontal comitant strabismus. Eye 2000; 14:873-878.
36. Lawson JM, Kousoulides L, Lee JP. Long-term results of botulinum toxin in consecutive and secondary exotropia: outcome in patients initially treated with botulinum toxin. J AAPOS 1998; 2:195-200.
37. Ozkan SB, Kir E, Dayanir V, Dundar SO. Botulinum toxin A in the treatment of adherence syndrome. Ophthalmic Surg Lasers Imaging 2003; 34:391-395.
38. Lyons CJ, Vickers SF, Lee JP. Botulinum toxin therapy in dysthyroid strabismus. Eye 1990; 4:538-542.
39. Rutstein RP, Cogen MS. Elimination of paradoxical diplopia following treatment with botulinum toxin and prism. Binocul Vis Strabismus Q 2004; 19:35-38.
40. Harris G, Dawson E, Lee J. Botulinum toxin to the lateral rectus for the treatment of esotropia with paradoxical diplopia. Strabismus 2001; 9:79-82.
41. Han SH, Lew H, Jeong CW, Lee JB. Effect of botulinum toxin A chemodenervation in sensory strabismus. J Pediatr Ophthalmol Strabismus 2001; 38:68-71.
42. Owens PL, Strominger MB, Rubin PA, Veronneau-Troutman S. Large-angle exotropia corrected by intraoperative botulinum toxin A and monocular recession resection surgery. J AAPOS 1998; 2:144-146.
43. Ruiz MF, Moreno M, Sanchez-Garrido CM, Rodriguez JM. Botulinum treatment of infantile esotropia with abduction nystagmus. J Pediatr Ophthalmol Strabismus 2000; 37:196-205.
44. Lennerstrand G, Nordbo OA, Tian S, et al. Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications. Acta Ophthalmol Scand 1998; 76:27-37.
45. Carruthers J. The treatment of congenital nystagmus with Botulinum. J Pediatr Ophthalmol Strabismus 1995; 32:306-308.
46. Tomsak RL, Remler BF, Averbuch-Heller L, et al. Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin. Am J Ophthalmol 1995; 119:489-496.
47. Menon GJ. Therapeutic external ophthalmoplegia with bilateral retrobulbar botulinum toxin - an effective treatment for acquired nystagmus with oscillopsia. Eye 2002; 16:804-806.
48. Kipioti A, Taylor RH. Botulinum toxin treatment of 'one and a half syndrome'. Br J Ophthalmol 2003; 87:918-919.